학술논문

Commentary on Japanese Guidelines for Food Allergy 2021 Chapter 7 Evaluation and treatment of immediate reaction / 第7章 即時型症状の重症度判定と対症療法
Document Type
Journal Article
Source
日本小児アレルギー学会誌 / Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology. 2022, 36(3):266
Subject
adrenaline
adrenaline auto-injector
anaphylaxis
immediate allergic reaction
アドレナリン
アドレナリン自己注射薬
アナフィラキシー
即時型アレルギー反応
Language
Japanese
ISSN
0914-2649
1882-2738
Abstract
Anaphylaxis is an acute, life-threatening systemic allergic reaction that may have a wide range of clinical manifestations. Majority of anaphylaxis reactions are not life-threatening; however, due to our inability to predict its severity, all anaphylaxis must be appropriately treated with intramuscular adrenaline. Adrenaline is the first-line pharmacotherapy for anaphylaxis, and diagnosis and management must occur rapidly. H1-antihistamines relieve itching but do not relieve life-threatening symptoms; therefore, like H2-receptor antagonists and glucocorticoids, they are adjunctive treatments and not appropriate as initial and lone treatments. Adrenaline auto injector is indicated for individuals who have a history or risk for anaphylaxis. They should be taught how to inject and equipped with a written anaphylaxis emergency action plan that aids them to recognize symptoms. The occurrence of unintentional injection of adrenaline from auto injectors is increasing. They need regular instructions on how to use adrenaline auto injectors correctly and safely.

Online Access